Biotech Updates

EuropaBio: 37 Years of Delays in GM Approval of the EU

September 12, 2012

The European Commission have years of delays in approval decisions on GM products, which when combined has a sum of 37 years, according to the position paper released by the European Association for Bioindustries' (EuropaBio). The EU legislation requires the Commission to follow certain timelines for decision making, but the timelines for approval of GM products regularly exceed the required timelines. This delay results to a continuously increasing backlog of GM products, while a number of developing counties are already adopting GM products and exporting their commodities to the EU.

Read the position paper at http://www.europabio.org/sites/default/files/position/37_years_of_delays_in_the_eu_approval_of_gm_products_europabio.pdf.